Related Experiment Video
Updated: Jun 11, 2025
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.4K
Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review
Karuna Nidhi Kaur1, Farah Niazi2, Dhruva Nandi3
1Division of Biomedical Informatics, Indian Council of Medical Research (ICMR), New Delhi, India.
Cancer Control : Journal of the Moffitt Cancer Center
|September 30, 2024
Summary
Introducing a gender-neutral Human Papillomavirus (HPV) vaccine in India is crucial. This ensures equitable access for all children, reduces the HPV burden, and prevents HPV-related cancers.
Area of Science:
- Public Health
- Immunology
- Oncology
Background:
- Human Papillomavirus (HPV) infection affects a significant portion of the global population, irrespective of gender, and is a major cause of various cancers.
- Current HPV vaccination strategies may not adequately protect males when vaccines are administered solely to females, highlighting a critical gap in public health initiatives.
- The stigma associated with HPV further necessitates a comprehensive approach to vaccination and disease prevention.
Purpose of the Study:
- To evaluate the necessity and feasibility of introducing a gender-neutral HPV vaccine, specifically GARDASIL-9, into India's national immunization program.
- To ensure equitable access to HPV vaccination for all children in India, regardless of gender.
- To mitigate the substantial public health burden posed by HPV infections and related cancers in the Indian population.
Main Methods:
- A comprehensive literature search was conducted using academic databases (Google Scholar, PubMed) and government health websites.
- Keywords used included "gender-neutral vaccine", "HPV vaccine", and "Indian population" to identify relevant studies.
- Inclusion criteria focused on HPV prevalence, vaccination awareness in both genders, cost-effectiveness, current vaccination status, and future perspectives in India.
Main Results:
- The introduction of a gender-neutral HPV vaccine in India is deemed imperative for comprehensive disease control.
- Including males in HPV vaccination programs significantly reduces the overall disease burden and contributes to diminishing the stigma surrounding HPV.
- A robust vaccination program, supported by public education and awareness campaigns, is essential for public health advancement.
Conclusions:
- Integrating a gender-neutral HPV vaccine into India's national immunization schedule is essential for equitable access and reducing the HPV burden.
- Such a program will foster a healthier community by preventing HPV-related cancers and improving overall public health outcomes in India.
- Addressing the HPV burden requires a multifaceted approach including vaccination, education, and policy integration.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
01:30Primary Healthcare Services
1.3K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.3K